Our Business
Investment Business
Our business model integrates funds and equity to acquire companies, enhance their value, and generate returns through IPOs and M&A transactions, thereby increasing our corporate value.
NANO MRNA Business
We are pioneering RNA-based drug discovery, including mRNA therapeutics. NANO Holdings is recognized as a domestic leader in mRNA medicine development.